What is atropine, including its mechanism of action, clinical uses, contraindications, and common adverse effects?

What is Atropine

Atropine is an antimuscarinic (anticholinergic) drug that competitively blocks acetylcholine at muscarinic receptors, primarily used in emergency medicine to treat symptomatic bradycardia and hemodynamically unstable cardiac rhythms. 1

Mechanism of Action

Atropine antagonizes muscarinic acetylcholine receptors on structures innervated by postganglionic cholinergic nerves, including the heart, smooth muscle, and exocrine glands 1. At the cardiac level, it:

• Blocks parasympathetic (vagal) influences on the sinoatrial and atrioventricular nodes
• Increases heart rate by facilitating sinoatrial conduction and enhancing sinus node automaticity
• Improves atrioventricular conduction 1, 2

The antagonism is competitive and surmountable—meaning higher concentrations of acetylcholine can overcome atropine's blockade 1.

Clinical Uses

Primary Indications

Symptomatic bradycardia with hemodynamic compromise is the main indication 3, 4. Specifically:

• Sinus bradycardia with symptoms or hemodynamic instability (Class IIa recommendation, dosage 0.5-1 mg IV, may repeat every 3-5 minutes to maximum 3 mg) 4
• Atrioventricular block associated with acute inferior myocardial infarction 4
• Bradycardia or asystole from vagal stimulation, cholinergic drugs, or anticholinesterase agents 1

Evidence of Efficacy

Atropine demonstrates benefit in hemodynamically unstable bradycardia and atrioventricular block with minimal risk of worsening outcomes 3. In a study of 131 patients with compromising bradycardia or AV block, approximately 47% had either partial (19.8%) or complete (27.5%) response to atropine, with adverse responses occurring in only 2.3% 5.

Other Uses

• Organophosphate and anticholinesterase poisoning 6
• Beta-blocker or calcium channel blocker overdose (as adjunct) 3
• Preoperative medication to reduce secretions and prevent vagal inhibition during anesthesia 1
• Treatment of nausea and vomiting 7

Contraindications

Absolute Contraindication

Heart transplant patients without autonomic reinnervation (Class III: Harm recommendation) 4. In these patients, atropine at standard doses causes paradoxical heart block or sinus arrest in 20% of cases because the denervated heart lacks parasympathetic innervation to block 3.

Relative Contraindications and Cautions

• Avoid in settings of coronary ischemia when using beta-agonists as alternatives (isoproterenol increases myocardial oxygen demand while decreasing coronary perfusion) 3
• Use cautiously in patients with complete heart block, as large doses may occasionally cause AV block and nodal rhythm 1

Adverse Effects

Common Side Effects

These relate directly to antimuscarinic action 1:

• Dry mouth (most common)
• Blurred vision and photophobia
• Tachycardia
• Anhidrosis (can produce heat intolerance, especially in infants and small children leading to "atropine fever")
• Constipation and urinary retention (particularly in elderly patients)
• Cutaneous vasodilation ("atropine flush")

Serious Adverse Effects

• Ventricular tachycardia or fibrillation 8
• Sustained sinus tachycardia 8
• Increased premature ventricular contractions 8
• Toxic psychosis and delirium 7, 8
• Hypertensive emergency (rare but documented: blood pressure can reach extreme levels like 294/121 mmHg) 9, 10

Critical Dosing Pitfalls

Paradoxical bradycardia occurs with doses <0.5 mg due to central vagotonic effects at the sinoatrial node 3, 4, 2. The sinoatrial node response is bimodal: lower doses slow heart rate, while higher doses (≥0.5 mg) accelerate it 3.

Major adverse effects correlate with:

• Initial doses ≥1.0 mg (compared to usual 0.5-0.6 mg)
• Total cumulative doses exceeding 2.5 mg over 2.5 hours 8

Allergic Reactions

Hypersensitivity reactions are occasional, including skin rashes that may progress to exfoliation 1. Severe anaphylaxis is rare despite extensive use 6. For patients with proven atropine allergy, alternatives include glycopyrrolate (peripheral antimuscarinic) combined with benzodiazepines or scopolamine for central effects 6.

Dosing Algorithm

For symptomatic bradycardia or AV block:

1. Administer 0.5-1 mg IV (never <0.5 mg to avoid paradoxical bradycardia)
2. May repeat every 3-5 minutes
3. Maximum total dose: 3 mg 4
4. Monitor closely for adverse effects if cumulative dose approaches 2.5 mg over short intervals 8

Onset and duration: Effects occur within 1 minute; half-life approximately 2 hours 4, 5.